This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Columbia University, The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Iowa Research Foundation. Active years: 2011-2015.
Company Filing History:
2 out of 2,547 
2 out of 3,688 
2 out of 925 
Years Active: 2011-2015
Title: The Innovations of Albert M Gold
Introduction
Albert M Gold is a notable inventor based in Frederick, MD (US), recognized for his contributions to the field of genetics and age-related diseases. He holds two patents that focus on methods for identifying individuals at risk for developing age-related macular degeneration (AMD). His work has significant implications for early diagnosis and potential treatment strategies.
Latest Patents
Gold's latest patents include innovative methods for identifying a subject at risk for developing AMD. These methods involve identifying specific protective or risk polymorphisms or genotypes from the subject's genetic material. The patents detail the use of microarrays and kits designed to practice these methods, which include polymorphisms in the BF, C2, and CFH genes. This research is crucial for advancing our understanding of genetic factors in AMD.
Career Highlights
Throughout his career, Albert M Gold has worked with prestigious institutions such as Columbia University and the University of Iowa Research Foundation. His research has contributed to the scientific community's understanding of genetic predispositions to diseases, particularly in the context of aging and vision health.
Collaborations
Gold has collaborated with esteemed colleagues, including Rando L Allikmets and Gregory S Hageman. These partnerships have enhanced the depth and impact of his research, leading to significant advancements in the field.
Conclusion
Albert M Gold's work exemplifies the intersection of genetics and medical innovation. His patents and research efforts continue to pave the way for improved diagnostic methods in age-related diseases.